VIP as a trophic factor in the CNS and cancer cells.

Abstract

The effects of vasoactive intestinal peptide (VIP) on the proliferation of central nervous system (CNS) and cancer cells were investigated. VIP has important actions during CNS development. During neurogenesis, VIP stimulates the proliferation and differentiation of brain neurons. Addition of VIP to embryonic mouse spinal cord cultures increases neuronal survival and activity dependent neurotrophic factor (ADNF) secretion from astroglial cells. VIP is an integrative regulator of brain growth and development during neurogenesis and embryogenesis. Also, VIP causes increased proliferation of human breast and lung cancer cells in vitro. VIP binds with high affinity to cancer cells, elevates the cAMP and increases gene expression of c-fos, c-jun, c-myc and vascular endothelial cell growth factor. The effects of VIP on cancer cells are reversed by VIPhybrid, a synthetic VPAC(1) receptor antagonist. VIPhyb inhibits the basal growth of lung cancer cells in vitro and tumors in vivo and potentiates the ability of chemotherapeutic drugs to kill cancer cells. Due to the high density of VPAC(1) receptors in cancer cells, VIP has been radiolabeled with 123I, 18F and 99mTc to image tumors. It remains to be determined if radiolabeled VIP analogs will be useful agents for early detection of cancer in patients.

• Authors: Terry W Moody, Joanna M Hill, Robert T Jensen
• Journal: Peptides (Peptides) Vol. 24 Issue 1 Pg. 163-77 (Jan 2003) ISSN: 0196-9781 [Print] United States
• PMID: 12576099 (Publication Type: Journal Article, Review)
• Copyright: Copyright 2002 Elsevier Science Inc.

Chemical References

• Vasoactive Intestinal Peptide

Topics

• Amino Acid Sequence
• Animals
• Central Nervous System (physiology)
• Humans
• Molecular Sequence Data
• Neoplasms (physiopathology)
• Second Messenger Systems
• Sequence Homology, Amino Acid
• Vasoactive Intestinal Peptide (chemistry, metabolism)